ATAI Life Sciences takes in $24m
ATAI Life Sciences, a biotech company focused on ending mental illnesses, has raised $24 million in convertible note financing.
ATAI Life Sciences, a biotech company focused on ending mental illnesses, has raised $24 million in convertible note financing.
Copyright PEI Media
Not for publication, email or dissemination